Have I got this right?
Some of you appear to be saying that the board of IIQ have decided not to progress research work on the BARD 1 Lung Cancer detection technology just to avoid having to pay Irmgard Irminger-Finger a possible bonus?
You're saying they would rather hold back the success of the company (and possibly even the survival of the company) just so they can cheat her out of a potential big pay day?
Spite in front of profits?
Doing something like that is more than just being small-minded. It would also make the company very unpopular with the their directly employed scientists, and research associates in the university sector.
Is that logical?
Ann: Update on Legal Proceedings and BARD1 Autoantibody Program, page-54
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
59.0¢ |
Change
-0.010(1.67%) |
Mkt cap ! $65.06M | |||
| Open | High | Low | Value | Volume |
| 60.0¢ | 60.0¢ | 59.0¢ | $17.47K | 29.17K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 41547 | 58.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 61.0¢ | 13799 | 4 |
View Market Depth
| Last trade - 15.51pm 26/07/2024 (20 minute delay) ? |
| IIQ (ASX) Chart |